204 related articles for article (PubMed ID: 25990232)
61. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
Martin JM; Green M; Barbadora KA; Wald ER
N Engl J Med; 2002 Apr; 346(16):1200-6. PubMed ID: 11961148
[TBL] [Abstract][Full Text] [Related]
62. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
63. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.
Seppälä H; Nissinen A; Yu Q; Huovinen P
J Antimicrob Chemother; 1993 Dec; 32(6):885-91. PubMed ID: 8144429
[No Abstract] [Full Text] [Related]
64. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.
de Azavedo JC; McGavin M; Duncan C; Low DE; McGeer A
Antimicrob Agents Chemother; 2001 Dec; 45(12):3504-8. PubMed ID: 11709331
[TBL] [Abstract][Full Text] [Related]
65. Antibiotic resistance and genotypic characteristics of group a streptococci associated with acute pharyngitis in Korea.
Kim S; Yong Lee N
Microb Drug Resist; 2004; 10(4):300-5. PubMed ID: 15650374
[TBL] [Abstract][Full Text] [Related]
66. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
Schoening TE; Wagner J; Arvand M
Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
[TBL] [Abstract][Full Text] [Related]
67. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea.
Kim S; Lee NY
J Antimicrob Chemother; 2004 Aug; 54(2):447-50. PubMed ID: 15269193
[TBL] [Abstract][Full Text] [Related]
68. Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.
Powell LM; Choi SJ; Haught BL; Demkowicz R; LaSala PR; Lukomski S
J Antimicrob Chemother; 2023 Oct; 78(10):2554-2558. PubMed ID: 37638394
[TBL] [Abstract][Full Text] [Related]
69. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
[TBL] [Abstract][Full Text] [Related]
70. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina.
Denamiel G; Llorente P; Carabella M; Rebuelto M; Gentilini E
J Vet Med B Infect Dis Vet Public Health; 2005 Apr; 52(3):125-8. PubMed ID: 15876224
[TBL] [Abstract][Full Text] [Related]
71. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
72. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
Weiss I; Gorodnitzky Z; Korenman Z; Yagupsky P
Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):20-3. PubMed ID: 9063669
[TBL] [Abstract][Full Text] [Related]
73. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
[TBL] [Abstract][Full Text] [Related]
74. Prevalence and identification of antibiotic-resistant scarlet fever group A Streptococcus strains in some paediatric cases at Shenzhen, China.
Sun L; Xiao Y; Huang W; Lai J; Lyu J; Ye B; Chen H; Gu B
J Glob Antimicrob Resist; 2022 Sep; 30():199-204. PubMed ID: 35618209
[TBL] [Abstract][Full Text] [Related]
75. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
[No Abstract] [Full Text] [Related]
76. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.
Melo-Cristino J; Fernandes ML
Microb Drug Resist; 1999; 5(3):219-25. PubMed ID: 10566873
[TBL] [Abstract][Full Text] [Related]
77. Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization.
Akata F; Oztürk D; Tansel O; Tatman-Otkun M; Otkun M; Fitoussi F; Bingen E; Tugrul M
Int J Antimicrob Agents; 2002 Dec; 20(6):461-3. PubMed ID: 12458142
[TBL] [Abstract][Full Text] [Related]
78. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
79. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.
Bingen E; Fitoussi F; Doit C; Cohen R; Tanna A; George R; Loukil C; Brahimi N; Le Thomas I; Deforche D
Antimicrob Agents Chemother; 2000 Jun; 44(6):1453-7. PubMed ID: 10817692
[TBL] [Abstract][Full Text] [Related]
80. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
